To Evaluate the Effects of Heating Device (Electronic Moxibustion) in Patients With Intradialytic Hypotension

Hemodialysis-Induced Symptom Clinical Trial

Official title:

To Evaluate the Effects of Heating Device (Electronic Moxibustion) in Patients With Intradialytic Hypotension

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03856151
• Other study ID #: 201801853A3
• Status: Completed
• Phase: N/A
• Start date: April 17, 2019
• Est. completion date: April 28, 2021

Study information

• Verified date: January 2019
• Source: Chang Gung Memorial Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to investigate the effects of heating device among otherwise stable patients with intradialytic hypotension

Description:

Intradialytic hypotension (IDH) is a common complication during hemodialysis (HD) which accounts up to 5 to 30 percent of all dialysis treatment and is associated with increased morbidity and mortality. The etiology of IDH is multifactorial, but intravascular volume depletion, autonomic neuropathy, and decreased cardiac reserve were the main factors. Several approaches were utilized to prevent IDH including adaptation of dialysis prescriptions, lengthening in dialysis time, avoiding food intake during dialysis, as well as limiting interdialytic sodium intake and administration of vasoconstrictor agents. However, it remains necessary to seek novel effective and safe inventions for IDH. To date, no studies have been done to evaluate the effectiveness of acupuncture and traditional moxibustion during HD for safety reasons (eg: risk of bleeding, burns and unpleasant smell). Therefore, the heating device appears to be a non-invasive and safe method for treating IDH. The investigators conduct a clinical trial using infrared heating devices without direct contact to the skin on low temperatures (56±8℃) in treating patients with IDH. 30 eligible participants diagnosed with IDH will be enrolled and divided into Group 1 and Group 2. Treatment 1# will be regular dialysis 3 times per week for 4 weeks. Treatment 2# will be regular dialysis 3 times per week plus "HEALTHY BOX" Powered heating pad on acupoint CV4 at the abdomen for 1 hour during dialysis, also for 4 weeks. For Group 1, each subject will receive Treatment 1# first, for Group 2, Treatment 2# will be received first. Then, it takes 2-week washout period with regular dialysis 3 times per week and make Group 1 and Group 2 crossover. Outcomes will include blood pressure changes, nursing intervention frequencies, IDH frequencies, the degree of cold intolerance, the degree of fatigue after dialysis and recovery time from fatigue after dialysis, the percentage of target ultrafiltration achieved and blood biochemistry. Data will be collected at the beginning of the study (baseline), end of Treatment 1 # , and end of Treatment 2#. Subjective questionnaires will be collected before and after each treatment period. The difference of evaluation scores between baseline and post-treatment will be analyzed using generalized linear mixed model. A value of P < 0.05 will be regarded as statistically significant for the above statistical analyses.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: April 28, 2021
• Est. primary completion date: April 20, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Age between 20 to 80-years-old

2. Willing to sign inform consent

3. Weekly hemodialysis 3 times per week, each time at least 180 minutes

4. During the past 2 months of hemodialysis, there is symptomatic intra-dialytic hypotension for over 15% of the time or under regular use of Midodrine.

Exclusion Criteria:

1. Pregnancy or breast-feeding

2. Not able to fill out questionnaires

3. Severe comorbidities, including cirrhosis, heart failure, autoimmune diseases and cancer

4. Diabetic peripheral neuropathy or patients insensitive to heat or unable to effectively express themselves in heated situations

5. Undergoing other types of alternative treatment, including Chinese medicine and regional remedies.

Related Conditions & MeSH terms

• Hemodialysis-Induced Symptom
• Hypotension
• Intra-dialytic Hypotension

Intervention

Device:
• "HEALTHY BOX" Powered heating pad (electronic moxibustion)
Using heating pad (electronic moxibustion) with insulating materials on low temperatures (56±8?) in treating patients with intra-dialytic hypotension

Locations

Country	Name	City	State
Taiwan	Keelung Chang Gung Memorial Hospital	Keelung

Sponsors (1)

Lead Sponsor	Collaborator
Chang Gung Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change of frequency of IDH episodes	times of IDH episode according to NADIR, KDOQI criteria	baseline, Treatment 1, Treatment 2
Primary	change of number of nursing interventions during HD	Trendelenburg position, man¬ual reduction of ultrafiltration rate, infusion of isotonic saline or hypertonic fluid, lowering of dialysate temperature	baseline, Treatment 1, Treatment 2
Secondary	change of the degree of cold intolerance	from 0 to 100; 0 is not cold, 100 is very cold	week 0,4,6,10
Secondary	change of the degree of fatigue after dialysis	scores from 0-10;0 is not tired, 10 is very tired	before and after Treatment1 & 2
Secondary	blood pressure changes	systolic, diastolic blood pressure and mean arterial pressure: mmHg	baseline, Treatment 1, Treatment 2
Secondary	change of recovery time from fatigue after dialysis	within minutes (0), when arriving home (0), at bedtime (2), the next morning (5), and by next HD (10)	before and after Treatment1 & 2